|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2376535 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09764997.4 |
| Date of filing the European patent application | 2009-12-08 | |
| (97) | Date of publication of the European application | 2011-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-12 |
| (46) | Date of publication of the claims translation | 2017-06-26 |
| (86) | Number | PCT/US2009/067104 |
| Date | 2009-12-08 |
| (87) | Number | WO 2010/077634 |
| Date | 2010-07-08 |
| (30) | Number | Date | Country code |
| 121092 P | 2008-12-09 | US |
| (72) |
IRVING, Bryan, US
CHEUNG, Jeanne, US
CHIU, Henry, US
LEHAR, Sophie, M., US
MAECKER, Heather, US
MARIATHASAN, Sanjeev, US
WU, Yan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-PD-L1 antikūnai ir jų panaudojimas T ląstelių funkcijos pagerinimui |
| ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION |
| Payment date | Validity (years) | Amount | |
| 2022-12-01 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-12-20 |